#ASCO25: Jazz outlines full survival data for lung cancer drug Zepzelcanews2025-05-22T21:00:21+00:00May 22nd, 2025|Endpoints News|
BioNTech invests £1B in growing UK footprint under expanded pact with governmentnews2025-05-21T15:04:51+00:00May 21st, 2025|Endpoints News|
Researchers reveal mixed results from vaccine for cocaine addictionnews2025-05-21T14:00:38+00:00May 21st, 2025|Endpoints News|
Genentech expands partnership with molecular glue biotech Orionisnews2025-05-21T11:00:29+00:00May 21st, 2025|Endpoints News|
How PureTech’s lung fibrosis drug stacks up against the competitionnews2025-05-21T10:48:26+00:00May 21st, 2025|Endpoints News|
Vinay Prasad makes first major imprint on FDA with new vaccine policynews2025-05-20T20:31:34+00:00May 20th, 2025|Endpoints News|
CRISPR Therapeutics partners with siRNA company, showing that gene editing isn’t the only answernews2025-05-20T18:52:16+00:00May 20th, 2025|Endpoints News|
Tourmaline Bio’s heart drug cuts inflammation as it seeks to compete with Novo, CSL’s assets news2025-05-20T14:45:32+00:00May 20th, 2025|Endpoints News|
Boehringer Ingelheim’s late-stage data for lung disease candidate underwhelm some analystsnews2025-05-19T16:44:46+00:00May 19th, 2025|Endpoints News|
Prime Medicine sidelines only clinical program, replaces CEO and lays off some staffnews2025-05-19T15:33:27+00:00May 19th, 2025|Endpoints News|
